Efficacy and Safety of Rivaroxaban Versus Low Molecular Weight Heparin for Treating Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis

被引:0
|
作者
Shrestha, Abhigan
Mainali, Nischal
Shrestha, Sajina
Jaiswal, Vikash
Rajak, Kripa
Edara, Ravi Sankar Reddy
Anil, K. C.
机构
关键词
D O I
10.1161/circ.150.suppl_1.4143604
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4143604
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery
    Mismetti, P
    Laporte, S
    Darmon, JY
    Buchmüller, A
    Decousus, H
    BRITISH JOURNAL OF SURGERY, 2001, 88 (07) : 913 - 930
  • [42] Efficacy and Safety of Apixaban versus Dalteparin as a Treatment for Cancer-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
    Arce-Huamani, Miguel A.
    Barboza, Joshuan J.
    Martinez-Herrera, Jose Fabian
    Torres-Roman, J. Smith
    Maguina, Jorge L.
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [43] The efficacy of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after knee and hip arthroplasty: A systematic review and meta-analysis of randomized controlled trials
    Salman, Loay A.
    Altahtamouni, Seif B.
    Khatkar, Harman
    Al-Ani, Abdallah
    Hameed, Shamsi
    Alvand, Abtin
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2024,
  • [44] Achieving higher efficacy without compromising safety with Factor XI inhibitors versus low-molecular-weight heparin for the prevention of venous thromboembolism in major orthopedic surgery - Systematic Review and Meta-Analysis
    Presume, Joao
    Ferreira, Jorge
    Ribeiras, Regina
    Mendes, Miguel
    CARDIOVASCULAR RESEARCH, 2022, 118 (SUPP 2)
  • [45] Low-molecular-weight heparin for treating venous thromboembolism
    Mahoney, M
    Kahn, M
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (01) : 77 - 77
  • [46] Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis
    Presume, Joao
    Ferreira, Jorge
    Ribeiras, Regina
    Mendes, Miguel
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (12) : 2930 - 2938
  • [47] Rivaroxaban versus enoxaparin for the prevention of recurrent venous thromboembolism in patients with cancer A meta-analysis
    Xing, Jiali
    Yin, Xiangbao
    Chen, Desheng
    MEDICINE, 2018, 97 (31)
  • [48] Does the low molecular weight heparins improve the efficacy and safety in the treatment of venous thromboembolism?: A meta-analysis
    Rocha, E
    Martinez, MA
    Panizo, C
    Montes, R
    Cuesta, B
    Rifón, J
    Aranguren, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 63 - 64
  • [49] Comparative Efficacy of Direct Oral Anticoagulants and Low-Molecular-Weight Heparin in Cancer-Associated Thromboembolism: A Systematic Review and Meta-Analysis
    Patel, Tirath
    Nadeem, Taha
    Shahbaz, Usman
    Tanveer, Fatima
    Ahsan, Muneeb
    Saeed, Usman
    Ahmed, Abdullah
    Kumar, Vinesh
    Jaffari, Syed M. Ibne Ali
    Zaman, Mohammad U.
    Kumar, Satesh
    Khatri, Mahima
    Varrassi, Giustino
    Vanga, Prasanthi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (06)
  • [50] Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis
    Li, Allen
    Brandt, Willem
    Brown, Cameron
    Wang, Tzu-Fei
    Ikesaka, Rick
    Delluc, Aurelien
    Wells, Phil
    Carrier, Marc
    THROMBOSIS RESEARCH, 2021, 208 : 58 - 65